Cuprina (Cayman) Limited... (CUPR)
NASDAQ: CUPR
· Real-Time Price · USD
1.19
-8.21 (-87.34%)
At close: Aug 15, 2025, 3:59 PM
Company Description
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds.
The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds.
Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
Cuprina (Cayman) Limited Class A Ordinary Shares
| Country | SG |
| IPO Date | Apr 10, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Yong Qi Quek |
Contact Details
Address: Blk 1090 Lower Delta Road #06-08 Singapore, SG | |
| Website | https://www.cuprina.com.sg |
Stock Details
| Ticker Symbol | CUPR |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001995704 |
| CUSIP Number | n/a |
| ISIN Number | KYG2592E1026 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yong Qi Quek | Chief Executive Officer & Director |
| Carl Marc Baptista | Founder, Chief Technology Officer & Director |
| Tat Jing Chan | Chief Financial Officer & Financial Controller |
| Dr. Naresh Waran Gnanasegaran | Head of R&D |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 21, 2025 | 6-K | Filing |
| Jul 01, 2025 | 6-K | Filing |
| Jun 30, 2025 | 6-K | Filing |
| Jun 04, 2025 | 6-K | Filing |
| May 14, 2025 | 20-F | Filing |
| May 08, 2025 | 6-K | Filing |
| May 08, 2025 | 6-K | Filing |
| May 05, 2025 | 6-K | Filing |
| Apr 17, 2025 | NT 20-F | Filing |
| Apr 11, 2025 | 6-K | Filing |